One suggested cause is that certain therapies, including DNA-damaging reagents, induce senescence in p53-proficient tumors, which may, in turn, lead to the emergence of the persister cells that secrete senescence-associated cytokines and, thereby, promote tumor cell survival35,36. The gene discussed is TP53; the disease is neoplasm.